As of Apr 21
| -0.06 / -1.84%|
The 5 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +87.50% increase from the last price of 3.20.
The current consensus among 7 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.